Quick10K

⚲

Wesco Aircraft

Filings

10-K	2019-09-30	Filed 2019-11-26
10-Q	2019-06-30	Filed 2019-08-09
10-Q	2019-03-31	Filed 2019-05-03
10-Q	2018-12-31	Filed 2019-02-01
10-K	2018-09-30	Filed 2018-11-16
10-Q	2018-06-30	Filed 2018-08-03
10-Q	2018-03-31	Filed 2018-05-04
10-Q	2017-12-31	Filed 2018-02-09
10-K	2017-09-30	Filed 2017-11-29
10-Q	2017-06-30	Filed 2017-08-09
10-Q	2017-03-31	Filed 2017-05-10
10-Q	2016-12-31	Filed 2017-02-08
10-K	2016-09-30	Filed 2016-11-28
10-Q	2016-06-30	Filed 2016-08-05
10-Q	2016-03-31	Filed 2016-05-06
10-Q	2015-12-31	Filed 2016-02-05
10-K	2015-09-30	Filed 2015-11-30
10-Q	2015-06-30	Filed 2015-08-07
10-Q	2015-03-31	Filed 2015-05-08
10-Q	2014-12-31	Filed 2015-02-06
10-K	2014-09-30	Filed 2014-12-01
10-Q	2014-06-30	Filed 2014-08-06
10-Q	2014-03-31	Filed 2014-05-12
10-Q	2013-12-31	Filed 2014-02-12
10-K	2013-09-30	Filed 2013-12-10
10-Q	2013-06-30	Filed 2013-08-06
10-Q	2013-03-31	Filed 2013-05-09
10-Q	2012-12-31	Filed 2013-02-08
10-K	2012-09-30	Filed 2012-11-30
10-Q	2012-06-30	Filed 2012-08-10
10-Q	2012-03-31	Filed 2012-05-11
10-Q	2011-12-31	Filed 2012-02-06
10-K	2011-09-30	Filed 2011-12-05
10-Q	2011-06-30	Filed 2011-08-17

Reports

8-K	2020-01-09
8-K	2020-01-02
8-K	2019-11-25
8-K	2019-10-24
8-K	2019-10-14
8-K	2019-09-13
8-K	2019-08-09
8-K	2019-08-08
8-K	2019-08-08
8-K	2019-05-02
8-K	2019-01-31
8-K	2019-01-24
8-K	2018-11-15
8-K	2018-09-14
8-K	2018-08-02
8-K	2018-06-26
8-K	2018-05-03
8-K	2018-02-09
8-K	2018-02-08
8-K	2018-01-25

Wesco Aircraft Financials

WAIR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	36	46	45	55	164	61	40	54	61	79	56	49	80	105	100	102	82	83	86	63	65	77	51	54	57	62	42	36	46	46	25	33	45	38
Accounts Receivable	100	97	100	108	116	130	130	146	146	156	159	320	299	302	286	281	272	253	238	275	261	249	247	267	264	256	254	287	302	284	297	317	333	328
Inventory										630	672	739	752	754	801	798	802	702	724	711	714	713	752	774	803	828	856	889	893	884	913	890	880	861
PP&E	22	21	17	16	20	44	22	21	21	55	28	48	50	79	48	47	46	88	46	48	49	103	50	51	51	116	50	48	46	123	44	47	54	148
Assets	1,284	1,301	1,299	1,338	1,467	1,537	1,531	1,570	1,583	1,631	1,650	2,374	2,392	2,412	2,423	2,395	2,370	2,021	2,030	2,029	2,000	1,956	1,958	2,000	1,774	1,754	1,758	1,812	1,830	1,789	1,813	1,818	1,836	1,795
Accounts Payable	46	53	55	68	67	80	73	88	88	99	94	156	144	160	175	163	157	150	166	159	170	182	173	181	176	184	162	194	193	180	185	181	216	221
Long-Term Debt	584	556	531	531	626	626	615	602	578	568	568	1,133	1,128	1,103	1,088	1,058	1,003	953	948	923	877	842	856	817	813	876	890	892	887	855	870	858	824	787
Liabilities	679	673	646	659	765	784	766	777	754	766	754	1,444	1,425	1,420	1,420	1,378	1,322	1,203	1,195	1,173	1,137	1,073	1,068	1,084	1,086	1,104	1,106	1,140	1,148	1,097	1,115	1,106	1,110	1,081
Stockholders' Equity		628	652	678	702	753	765	793	828	865	895	931	966	992	1,003	1,018	1,048	818	834	856	863	883	890	916	688	650	652	672	682	692	698	711	726	713


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	180	181	193	182	189	212	211	226	230	234	225	327	396	408	374	386	369	370	360	377	375	366	339	365	364	362	363	390	410	407	395	426	442	432
Cost of Revenue	111	109	119	118	122	133	137	145	148	149	147	228	274	288	262	271	259	381	263	274	276	270	250	270	274	274	269	284	306	308	297	318	337	342
Gross Profit	69	73	73	64	67	79	74	81	82	85	78	99	122	120	112	115	109	6	97	102	99	95	89	95	90	87	94	106	104	99	98	109	106	90
R&D
SG&A											37	57	69	72	73	74	73	51	60	61	59	55	63	63	66	68	70	73	75	76	76	79	83	86
Tax	10	15	15	16	8	8	9	14	14	15	13	12	16	14	-10	13	8	-118	8	9	9	7	2	6	-67	48	13	6	6	2	3	5	-7	2
Net Income	14																														6	12	14


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating			23	5	18	9	4	28	25	28	-26	-8	36	51	11	38	34	57	11	4	52	51	-28	-6	1	6	-30	-6	17	37	-32	26	56	37
Cash Investing			2	-1	-5	-133	-1	-1	-1	-6	-2	-562	-5	-3	-2	-2	-2	-5	-1	-4	-4	-3	-1	-3	-3	-2	-1	-2	-1	-2	-2	-6	-8	-5
Cash Financing			-26	6	95	21	-25	-12	-17	-4	4	563	1	-25	-15	-30	-55	-51	-5	-23	-44	-36	5	11	4	0	12	1	-5	-34	14	-13	-35	-40